{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:38:17Z","timestamp":1756463897862,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T00:00:00Z","timestamp":1450828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s12020-015-0832-2","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T01:04:22Z","timestamp":1450832662000},"page":"587-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impaired immune regulation after radioiodine therapy for Graves\u2019 disease and the protective effect of Methimazole"],"prefix":"10.1007","volume":"52","author":[{"given":"Sarah","family":"C\u00f4t\u00e9-Bigras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viet","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Turcotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Rola-Pleszczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Verreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Rottembourg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"issue":"6","key":"832_CR1","first-page":"673","volume":"19","author":"B Rapoport","year":"1998","unstructured":"B. Rapoport, G.D. Chazenbalk, J.C. Jaume, S.M. McLachlan, The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr. Rev. 19(6), 673\u2013716 (1998)","journal-title":"Endocr. Rev."},{"issue":"2","key":"832_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/thy.1998.8.193","volume":"8","author":"RS Bahn","year":"1998","unstructured":"R.S. Bahn, C.M. Dutton, W. Joba, A.E. Heufelder, Thyrotropin receptor expression in cultured Graves\u2019 orbital preadipocyte fibroblasts is stimulated by thyrotropin. Thyroid 8(2), 193\u2013196 (1998)","journal-title":"Thyroid"},{"issue":"8","key":"832_CR3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"R.S. Bahn, Graves\u2019 ophthalmopathy. N. Engl. J. Med. 362(8), 726\u2013738 (2010). doi: 10.1056\/NEJMra0905750","journal-title":"N. Engl. J. Med."},{"key":"832_CR4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"S. Sakaguchi, Naturally arising CD4\u00a0+\u00a0regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531\u2013562 (2004). doi: 10.1146\/annurev.immunol.21.120601.141122","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"832_CR5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI200423594","volume":"114","author":"DI Godfrey","year":"2004","unstructured":"D.I. Godfrey, M. Kronenberg, Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114(10), 1379\u20131388 (2004). doi: 10.1172\/JCI23594","journal-title":"J. Clin. Invest."},{"issue":"9","key":"832_CR6","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1210\/jc.2005-2337","volume":"91","author":"M Marazuela","year":"2006","unstructured":"M. Marazuela, M.A. Garcia-Lopez, N. Figueroa-Vega, H. de la Fuente, B. Alvarado-Sanchez, A. Monsivais-Urenda, F. Sanchez-Madrid, R. Gonzalez-Amaro, Regulatory T cells in human autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 91(9), 3639\u20133646 (2006). doi: 10.1210\/jc.2005-2337","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"832_CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1507\/endocrj.K07E-006","volume":"55","author":"M Watanabe","year":"2008","unstructured":"M. Watanabe, Y. Nakamura, F. Matsuzuka, Y. Takamura, A. Miyauchi, Y. Iwatani, Decrease of intrathyroidal CD161\u00a0+\u00a0Valpha24\u00a0+\u00a0Vbeta11\u00a0+\u00a0NKT cells in Graves\u2019 disease. Endocr. J. 55(1), 199\u2013203 (2008)","journal-title":"Endocr. J."},{"issue":"5","key":"832_CR8","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1210\/en.2005-1024","volume":"147","author":"O Saitoh","year":"2006","unstructured":"O. Saitoh, Y. Nagayama, Regulation of Graves\u2019 hyperthyroidism with naturally occurring CD4\u00a0+\u00a0CD25\u00a0+\u00a0regulatory T cells in a mouse model. Endocrinology 147(5), 2417\u20132422 (2006). doi: 10.1210\/en.2005-1024","journal-title":"Endocrinology"},{"issue":"3","key":"832_CR9","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.4049\/jimmunol.173.3.2167","volume":"173","author":"Y Nagayama","year":"2011","unstructured":"Y. Nagayama, K. Watanabe, M. Niwa, S.M. McLachlan, B. Rapoport, Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves\u2019 hyperthyroidism. J. Immunol. 173(3), 2167\u20132173 (2011)","journal-title":"J. Immunol."},{"issue":"8","key":"832_CR10","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","volume":"186","author":"C Mao","year":"2011","unstructured":"C. Mao, S. Wang, Y. Xiao, J. Xu, Q. Jiang, M. Jin, X. Jiang, H. Guo, G. Ning, Y. Zhang, Impairment of regulatory capacity of CD4\u00a0+\u00a0CD25\u00a0+\u00a0regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves\u2019 disease. J. Immunol. 186(8), 4734\u20134743 (2011). doi: 10.4049\/jimmunol.0904135","journal-title":"J. Immunol."},{"issue":"3","key":"832_CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08916934.2013.879862","volume":"47","author":"M Klatka","year":"2014","unstructured":"M. Klatka, E. Grywalska, M. Partyka, M. Charytanowicz, E. Kiszczak-Bochynska, J. Rolinski, Th17 and Treg cells in adolescents with Graves\u2019 disease. Impact of treatment with methimazole on these cell subsets. Autoimmunity 47(3), 201\u2013211 (2014). doi: 10.3109\/08916934.2013.879862","journal-title":"Autoimmunity"},{"issue":"7","key":"832_CR12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/thy.2012.0514","volume":"23","author":"AB Glick","year":"2013","unstructured":"A.B. Glick, A. Wodzinski, P. Fu, A.D. Levine, D.N. Wald, Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid 23(7), 871\u2013878 (2013). doi: 10.1089\/thy.2012.0514","journal-title":"Thyroid"},{"issue":"4","key":"832_CR13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.2009.03544.x","volume":"71","author":"D Pan","year":"2009","unstructured":"D. Pan, Y.H. Shin, G. Gopalakrishnan, J. Hennessey, L.J. De Groot, Regulatory T cells in Graves\u2019 disease. Clin. Endocrinol. (Oxf) 71(4), 587\u2013593 (2009). doi: 10.1111\/j.1365-2265.2009.03544.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"2","key":"832_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","volume":"14","author":"CR Grant","year":"2015","unstructured":"C.R. Grant, R. Liberal, G. Mieli-Vergani, D. Vergani, M.S. Longhi, Regulatory T-cells in autoimmune diseases: challenges, controversies and\u2013yet\u2013unanswered questions. Autoimmun. Rev. 14(2), 105\u2013116 (2015). doi: 10.1016\/j.autrev.2014.10.012","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"832_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","volume":"117","author":"C Dejaco","year":"2006","unstructured":"C. Dejaco, C. Duftner, B. Grubeck-Loebenstein, M. Schirmer, Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117(3), 289\u2013300 (2006). doi: 10.1111\/j.1365-2567.2005.02317.x","journal-title":"Immunology"},{"issue":"7","key":"832_CR16","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","volume":"203","author":"N Seddiki","year":"2006","unstructured":"N. Seddiki, B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S.I. Alexander, R. Nanan, A. Kelleher, Fazekas de St Groth, B.: Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203(7), 1693\u20131700 (2006). doi: 10.1084\/jem.20060468","journal-title":"J. Exp. Med."},{"issue":"4","key":"832_CR17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"J.D. Fontenot, M.A. Gavin, A.Y. Rudensky, Foxp3 programs the development and function of CD4\u00a0+\u00a0CD25\u00a0+\u00a0regulatory T cells. Nat. Immunol. 4(4), 330\u2013336 (2003). doi: 10.1038\/ni904","journal-title":"Nat. Immunol."},{"issue":"5609","key":"832_CR18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"S. Hori, T. Nomura, S. Sakaguchi, Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609), 1057\u20131061 (2003). doi: 10.1126\/science.1079490","journal-title":"Science"},{"issue":"3","key":"832_CR19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.180.3.1171","volume":"180","author":"P Dellabona","year":"1994","unstructured":"P. Dellabona, E. Padovan, G. Casorati, M. Brockhaus, A. Lanzavecchia, An invariant V alpha 24-J alpha Q\/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J. Exp. Med. 180(3), 1171\u20131176 (1994)","journal-title":"J. Exp. Med."},{"issue":"1","key":"832_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.178.1.1","volume":"178","author":"S Porcelli","year":"1993","unstructured":"S. Porcelli, C.E. Yockey, M.B. Brenner, S.P. Balk, Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha\/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J. Exp. Med. 178(1), 1\u201316 (1993)","journal-title":"J. Exp. Med."},{"issue":"2","key":"832_CR21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/clim.2001.5060","volume":"100","author":"HJ Vliet van der","year":"2001","unstructured":"H.J. van der Vliet, B.M. von Blomberg, N. Nishi, M. Reijm, A.E. Voskuyl, A.A. van Bodegraven, C.H. Polman, T. Rustemeyer, P. Lips, A.J. van den Eertwegh, G. Giaccone, R.J. Scheper, H.M. Pinedo, Circulating V(alpha24+) Vbeta11\u00a0+\u00a0NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100(2), 144\u2013148 (2001). doi: 10.1006\/clim.2001.5060","journal-title":"Clin. Immunol."},{"issue":"4","key":"832_CR22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.humimm.2009.01.012","volume":"70","author":"A Roman-Gonzalez","year":"2009","unstructured":"A. Roman-Gonzalez, M.E. Moreno, J.M. Alfaro, F. Uribe, G. Latorre-Sierra, M.T. Rugeles, C.J. Montoya, Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients. Hum. Immunol. 70(4), 262\u2013268 (2009). doi: 10.1016\/j.humimm.2009.01.012","journal-title":"Hum. Immunol."},{"issue":"6","key":"832_CR23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/1381612013397898","volume":"7","author":"R Volpe","year":"2001","unstructured":"R. Volpe, The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyte-immunocyte signalling: a review. Curr. Pharm. Des. 7(6), 451\u2013460 (2001)","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"832_CR24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJM198008073030603","volume":"303","author":"AM McGregor","year":"1980","unstructured":"A.M. McGregor, M.M. Petersen, S.M. McLachlan, P. Rooke, B.R. Smith, R. Hall, Carbimazole and the autoimmune response in Graves\u2019 disease. N. Engl. J. Med. 303(6), 302\u2013307 (1980). doi: 10.1056\/NEJM198008073030603","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"832_CR25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5603\/FHC.2014.0008","volume":"52","author":"M Klatka","year":"2014","unstructured":"M. Klatka, L. Kaszubowska, E. Grywalska, M. Wasiak, L. Szewczyk, J. Foerster, M. Cyman, J. Rolinski, Treatment of Graves\u2019 disease with methimazole in children alters the proliferation of Treg cells and CD3\u00a0+\u00a0T lymphocytes. Folia Histochem. Cytobiol. 52(1), 69\u201377 (2014). doi: 10.5603\/FHC.2014.0008","journal-title":"Folia Histochem. Cytobiol."},{"issue":"2","key":"832_CR26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","volume":"338","author":"L Bartalena","year":"1998","unstructured":"L. Bartalena, C. Marcocci, F. Bogazzi, L. Manetti, M.L. Tanda, E. Dell\u2019Unto, G. Bruno-Bossio, M. Nardi, M.P. Bartolomei, A. Lepri, G. Rossi, E. Martino, A. Pinchera, Relation between therapy for hyperthyroidism and the course of Graves\u2019 ophthalmopathy. N. Engl. J. Med. 338(2), 73\u201378 (1998). doi: 10.1056\/NEJM199801083380201","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"832_CR27","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","volume":"326","author":"L Tallstedt","year":"1992","unstructured":"L. Tallstedt, G. Lundell, O. Torring, G. Wallin, J.G. Ljunggren, H. Blomgren, A. Taube, Occurrence of ophthalmopathy after treatment for Graves\u2019 hyperthyroidism. The Thyroid Study Group. N. Engl. J. Med. 326(26), 1733\u20131738 (1992). doi: 10.1056\/NEJM199206253262603","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"832_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","volume":"158","author":"P Laurberg","year":"2008","unstructured":"P. Laurberg, G. Wallin, L. Tallstedt, M. Abraham-Nordling, G. Lundell, O. Torring, TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur. J. Endocrinol. 158(1), 69\u201375 (2008). doi: 10.1530\/EJE-07-0450","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"832_CR29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","volume":"352","author":"DS Cooper","year":"2005","unstructured":"D.S. Cooper, Antithyroid drugs. N. Engl. J. Med. 352(9), 905\u2013917 (2005). doi: 10.1056\/NEJMra042972","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"832_CR30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1530\/eje.0.1510467","volume":"151","author":"VA Andrade","year":"2004","unstructured":"V.A. Andrade, J.L. Gross, A.L. Maia, Serum thyrotropin-receptor autoantibodies levels after I therapy in Graves\u2019 patients: effect of pretreatment with methimazole evaluated by a prospective, randomized study. Eur. J. Endocrinol. 151(4), 467\u2013474 (2004)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"832_CR31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"C.L. Bennett, J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, L. Whitesell, T.E. Kelly, F.T. Saulsbury, P.F. Chance, H.D. Ochs, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27(1), 20\u201321 (2001). doi: 10.1038\/83713","journal-title":"Nat. Genet."},{"issue":"7","key":"832_CR32","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W Liu","year":"2006","unstructured":"W. Liu, A.L. Putnam, Z. Xu-Yu, G.L. Szot, M.R. Lee, S. Zhu, P.A. Gottlieb, P. Kapranov, T.R. Gingeras, B.F.S. Groth, C. Clayberger, D.M. Soper, S.F. Ziegler, J.S. Bluestone, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203(7), 1701\u20131711 (2006). doi: 10.1084\/jem.20060772","journal-title":"J. Exp. Med."},{"issue":"4","key":"832_CR33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.immuni.2008.03.003","volume":"28","author":"MO Li","year":"2008","unstructured":"M.O. Li, R.A. Flavell, Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28(4), 468\u2013476 (2008). doi: 10.1016\/j.immuni.2008.03.003","journal-title":"Immunity"},{"issue":"2","key":"832_CR34","first-page":"542","volume":"79","author":"AW Kung","year":"1994","unstructured":"A.W. Kung, C.C. Yau, A. Cheng, The incidence of ophthalmopathy after radioiodine therapy for Graves\u2019 disease: prognostic factors and the role of methimazole. J. Clin. Endocrinol. Metab. 79(2), 542\u2013546 (1994). doi: 10.1210\/jcem.79.2.7913934","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"832_CR35","author":"J Zhou","year":"2011","unstructured":"J. Zhou, M. Bi, C. Fan, X. Song, R. Yang, S. Zhao, L. Li, Y. Li, W. Teng, Z. Shan, Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves\u2019 hyperthyroidism. Clin. Exp. Med (2011). doi: 10.1007\/s10238-011-0137-6","journal-title":"Clin. Exp. Med"},{"key":"832_CR36","author":"A Rodriguez-Munoz","year":"2015","unstructured":"A. Rodriguez-Munoz, M. Vitales-Noyola, A. Ramos-Levi, A. Serrano-Somavilla, R. Gonzalez-Amaro, M. Marazuela, Levels of regulatory T cells CD69NKG2D IL-10 are increased in patients with autoimmune thyroid disorders. Endocrine (2015). doi: 10.1007\/s12020-015-0662-2","journal-title":"Endocrine"},{"key":"832_CR37","author":"R Gonzalez-Amaro","year":"2015","unstructured":"R. Gonzalez-Amaro, M. Marazuela, T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. Endocrine (2015). doi: 10.1007\/s12020-015-0759-7","journal-title":"Endocrine"},{"issue":"5\u20136","key":"832_CR38","first-page":"567","volume":"58","author":"G Afshan","year":"2012","unstructured":"G. Afshan, N. Afzal, S. Qureshi, CD4\u00a0+\u00a0CD25(hi) regulatory T cells in healthy males and females mediate gender difference in the prevalence of autoimmune diseases. Clin. Lab. 58(5\u20136), 567\u2013571 (2012)","journal-title":"Clin. Lab."},{"issue":"11","key":"832_CR39","doi-asserted-by":"crossref","first-page":"e27038","DOI":"10.1371\/journal.pone.0027038","volume":"6","author":"J Hua","year":"2011","unstructured":"J. Hua, S. Liang, X. Ma, T.J. Webb, J.P. Potter, Z. Li, The interaction between regulatory T cells and NKT cells in the liver: a CD1d bridge links innate and adaptive immunity. PLoS One 6(11), e27038 (2011). doi: 10.1371\/journal.pone.0027038","journal-title":"PLoS One"},{"issue":"1","key":"832_CR40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00199848","volume":"26","author":"M Awwad","year":"1988","unstructured":"M. Awwad, R.J. North, Sublethal, whole-body ionizing irradiation can be tumor promotive or tumor destructive depending on the stage of development of underlying antitumor immunity. Cancer Immunol. Immunother. 26(1), 55\u201360 (1988)","journal-title":"Cancer Immunol. Immunother."},{"issue":"11","key":"832_CR41","first-page":"4106","volume":"84","author":"BM Jones","year":"1999","unstructured":"B.M. Jones, C.C. Kwok, A.W. Kung, Effect of radioactive iodine therapy on cytokine production in Graves\u2019 disease: transient increases in interleukin-4 (IL-4), IL-6, IL-10, and tumor necrosis factor-alpha, with longer term increases in interferon-gamma production. J. Clin. Endocrinol. Metab. 84(11), 4106\u20134110 (1999). doi: 10.1210\/jcem.84.11.6128","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"832_CR42","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1210\/jc.2006-1571","volume":"92","author":"A Antonelli","year":"2007","unstructured":"A. Antonelli, M. Rotondi, P. Fallahi, M. Grosso, G. Boni, S.M. Ferrari, P. Romagnani, M. Serio, G. Mariani, E. Ferrannini, Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves\u2019 disease or toxic nodular goiter. J. Clin. Endocrinol. Metab. 92(4), 1485\u20131490 (2007). doi: 10.1210\/jc.2006-1571","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"832_CR43","first-page":"35","volume":"5","author":"MD Turowska","year":"2002","unstructured":"M.D. Turowska, D. Turowski, J. Wysocka, F. Rogowski, The effects of radioiodine therapy on peripheral blood lymphocyte subpopulations in patients with Graves\u2019 disease. Preliminary report. Nucl. Med. Rev. Cent. East Eur. 5(1), 35\u201338 (2002)","journal-title":"Nucl. Med. Rev. Cent. East Eur."},{"issue":"7","key":"832_CR44","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.190.7.995","volume":"190","author":"C Asseman","year":"1999","unstructured":"C. Asseman, S. Mauze, M.W. Leach, R.L. Coffman, F. Powrie, An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190(7), 995\u20131004 (1999)","journal-title":"J. Exp. Med."},{"issue":"7","key":"832_CR45","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/thy.2010.1640","volume":"20","author":"KA Ponto","year":"2010","unstructured":"K.A. Ponto, S. Zang, G.J. Kahaly, The tale of radioiodine and Graves\u2019 orbitopathy. Thyroid 20(7), 785\u2013793 (2010). doi: 10.1089\/thy.2010.1640","journal-title":"Thyroid"},{"issue":"18","key":"832_CR46","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","volume":"113","author":"G Beriou","year":"2009","unstructured":"G. Beriou, C.M. Costantino, C.W. Ashley, L. Yang, V.K. Kuchroo, C. Baecher-Allan, D.A. Hafler, IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113(18), 4240\u20134249 (2009). doi: 10.1182\/blood-2008-10-183251","journal-title":"Blood"},{"issue":"2","key":"832_CR47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.188.2.287","volume":"188","author":"AM Thornton","year":"1998","unstructured":"A.M. Thornton, E.M. Shevach, CD4\u00a0+\u00a0CD25\u00a0+\u00a0immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188(2), 287\u2013296 (1998)","journal-title":"J. Exp. Med."},{"issue":"12","key":"832_CR48","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/intimm\/10.12.1969","volume":"10","author":"T Takahashi","year":"1998","unstructured":"T. Takahashi, Y. Kuniyasu, M. Toda, N. Sakaguchi, M. Itoh, M. Iwata, J. Shimizu, S. Sakaguchi, Immunologic self-tolerance maintained by CD25\u00a0+\u00a0CD4\u00a0+\u00a0naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic\/suppressive state. Int. Immunol. 10(12), 1969\u20131980 (1998)","journal-title":"Int. Immunol."},{"issue":"11","key":"832_CR49","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.193.11.1285","volume":"193","author":"H Jonuleit","year":"2001","unstructured":"H. Jonuleit, E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, A.H. Enk, Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193(11), 1285\u20131294 (2001)","journal-title":"J. Exp. Med."},{"issue":"2","key":"832_CR50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03345148","volume":"26","author":"F Bogazzi","year":"2003","unstructured":"F. Bogazzi, E. Martino, L. Bartalena, Antithyroid drug treatment prior to radioiodine therapy for Graves\u2019 disease: yes or no? J. Endocrinol. Invest. 26(2), 174\u2013176 (2003)","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"832_CR51","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/147323000903700235","volume":"37","author":"GM Shi","year":"2009","unstructured":"G.M. Shi, Q. Xu, C.Y. Zhu, Y.L. Yang, Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves\u2019 disease. J. Int. Med. Res. 37(2), 576\u2013582 (2009)","journal-title":"J. Int. Med. Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0832-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-015-0832-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0832-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:57:15Z","timestamp":1559426235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-015-0832-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1007\/s12020-015-0832-2","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"type":"print","value":"1355-008X"},{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}